{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:29:28Z","timestamp":1789910968535,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.atherosclerosis.2011.06.010","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T23:54:18Z","timestamp":1309046058000},"page":"308-321","source":"Crossref","is-referenced-by-count":40,"title":["Where does the interplay between cholesterol absorption and synthesis in the context of statin and\/or ezetimibe treatment stand today?"],"prefix":"10.1016","volume":"217","author":[{"given":"Olivier","family":"S. Descamps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Missault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0005","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1194\/jlr.P800042-JLR200","article-title":"Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers","volume":"50","author":"van Himbergen","year":"2009","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/ATVBAHA.109.196550","article-title":"Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway","volume":"30","author":"van Himbergen","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/euhj.2001.3071","article-title":"Why some patients respond poorly to statins and how this might be remedied","volume":"23","author":"Thompson","year":"2002","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.lfs.2006.10.006","article-title":"Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?","volume":"80","author":"Santosa","year":"2007","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00199871","article-title":"Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects","volume":"46","author":"Miserez","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.metabol.2004.12.020","article-title":"Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment","volume":"54","author":"Lahoz","year":"2005","journal-title":"Metabolism"},{"issue":"4 Suppl","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0035","first-page":"III35","article-title":"Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia","volume":"87","author":"Leitersdorf","year":"1993","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9149(02)02599-7","article-title":"Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS)","volume":"90","author":"Streja","year":"2002","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0045","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/CIRCULATIONAHA.104.526848","article-title":"Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"112","author":"Packard","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0050","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.CIR.44.5.842","article-title":"Cholesterol production in obesity","volume":"44","author":"Miettinen","year":"1974","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0055","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.ATV.20.5.1340","article-title":"Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol","volume":"20","author":"Miettinen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ajcn\/49.4.629","article-title":"Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels","volume":"49","author":"Miettinen","year":"1989","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjcard.2005.09.134","article-title":"Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and PHARMACOGENETICS (CAP) Study","volume":"97","author":"Simon","year":"2006","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.CIR.85.4.1293","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins","volume":"85","author":"Shear","year":"1992","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0075","first-page":"S158","article-title":"Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center","volume":"12","author":"Williams","year":"2002","journal-title":"Ethn Dis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2009-1952","article-title":"Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin","volume":"95","author":"Lakoski","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0085","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous","volume":"18","author":"Couture","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.P001792","article-title":"A gene score of nine LDL and HDL regulating genes is associated with fluvastatin induced cholesterol changes in women","volume":"51","author":"Hamrefors","year":"2010","journal-title":"J Lipid Res"},{"issue":"9A","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0095","doi-asserted-by":"crossref","first-page":"65K","DOI":"10.1016\/j.amjcard.2005.08.011","article-title":"Pharmacogenomics of statin responsiveness","volume":"96","author":"Kajinami","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7138","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"for the Finnish 4S Investigators. Baseline serum cholestanol predicts recurrent coronary events in a subgroup of the Scandinavian Simvastatin Survival Study (4S)","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0105","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0021-9258(18)64995-6","article-title":"The origin of serum cholesterol in the rat; diet versus synthesis","volume":"224","author":"Morris","year":"1957","journal-title":"J Biol Chem"},{"issue":"4746","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ajcn\/43.1.92","article-title":"Serum plant sterols and their relation to cholesterol absorption","volume":"43","author":"Tilvis","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(94)05474-W","article-title":"Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination","volume":"115","author":"Vanhanen","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0125","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0026-0495(91)90013-M","volume":"40","author":"Glueck","year":"1991","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1185\/030079908X253663","article-title":"Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia","volume":"24","author":"Assmann","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0026-0495(89)90252-7","article-title":"Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men","volume":"38","author":"Miettinen","year":"1989","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0140","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-2275(20)40679-0","article-title":"Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man","volume":"19","author":"Crouse","year":"1978","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00041433-200104000-00007","article-title":"Genetic basis of sitosterolemia","volume":"12","author":"Lee","year":"2001","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1194\/jlr.M001487","article-title":"Baseline cholesterol absorption and the response to ezetimibe\/simvastatin therapy: a post-hoc analysis of the ENHANCE trial","volume":"51","author":"Jakulj","year":"2010","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(02)00054-0","article-title":"Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients","volume":"164","author":"Miettinen","year":"2002","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mlc.2003.9","article-title":"Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins","volume":"141","author":"Miettinen","year":"2003","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1194\/jlr.M900032-JLR200","volume":"51","author":"Matthan","year":"2010","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1067\/mlc.2003.9","article-title":"Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins","volume":"141","author":"Miettinen","year":"2003","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9150(01)00608-6","article-title":"Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients","volume":"160","author":"Gylling","year":"2002","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.ejcn.1602969","article-title":"Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food","volume":"63","author":"Houweling","year":"2009","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0185","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.atherosclerosis.2006.10.036","article-title":"Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients","volume":"194","author":"Pisciotta","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0190","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-2275(20)38456-X","article-title":"Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans","volume":"29","author":"Kempen","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-2275(20)43088-3","article-title":"Synthesis in man","volume":"10","author":"Grundy","year":"1969","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0200","first-page":"202","article-title":"Abnormalities of cholesterol turnover in hypercholesterolemic (Type 11) patients","volume":"88","author":"Bhattacharyya","year":"1976","journal-title":"J Lab Clin Med"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0205","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0210","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima\u2013media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0215","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2008.10.031","article-title":"Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial","volume":"52","author":"Fleg","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0220","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/0091270009337011","article-title":"The vytorin on carotid intima-media thickness and overall arterial rigidity (VYCTOR) study","volume":"49","author":"Meaney","year":"2009","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2010.08.012","article-title":"Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9438 patients with chronic kidney disease","volume":"160","year":"2010","journal-title":"Am Heart J"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(94)05474-W","article-title":"Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination","volume":"115","author":"Vanhanen","year":"1995","journal-title":"Atherosclerosis"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2011.06.010_bib0240","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000034044.95911.DC","article-title":"Inhibition of intestinal cholesterol absorption by ezetimibe in humans","volume":"106","author":"Sudhop","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0245","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1194\/jlr.P900004-JLR200","article-title":"Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and\/or simvastatin in men","volume":"50","author":"Sudhop","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005344-198005000-00006","article-title":"Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat","volume":"2","author":"Turley","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1194\/jlr.M400475-JLR200","article-title":"Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption","volume":"46","author":"Repa","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0260","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacl.2008.01.008","article-title":"The role of Niemann-Pick C1 \u2013 Like 1 (NPC1L1) in intestinal sterol absorption","volume":"2","author":"Turley","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0265","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1093\/jn\/133.9.2741","article-title":"Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet","volume":"133","author":"Naumann","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.atherosclerosis.2011.06.010_bib0270","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1194\/jlr.P000471","article-title":"Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort","volume":"51","author":"Escurriol","year":"2010","journal-title":"J Lipid Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011004874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011004874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T19:54:17Z","timestamp":1637956457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011004874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0021915011004874"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}